SERS Nanolaminate Probe for Picomolar Catecholamine Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting dopamine, a critical neurotransmitter, face challenges in sensitivity and specificity, particularly in diagnosing neurological disorders, as they can only reliably measure down to the nanomolar range and are affected by electroactive interferents in extracellular fluids.
Innovation Solution
A surface-enhanced Raman spectroscopy complex probe is developed, comprising a nanolaminate with a nanogap and modified to bind to the amine group of catecholamines, combined with metal nanoparticles modified to bind to the diol group, creating a reinforced hotspot for enhanced detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional DA detection methods (electrochemistry, chromatography, fluorescence) are used, then the detection can be performed with simple equipment and procedures, but the sensitivity is limited to nanomolar range which is insufficient for neurological disorder diagnosis
Solution Approach 1:
The patent employs a composite SERS detection platform combining plasmonic nanomaterials (gold/silver nanoparticles) with molecularly imprinted polymers (MIPs) and Raman-reporting molecules. This composite structure achieves picomolar-level detection sensitivity by integrating the plasmonic enhancement effect with the specific recognition capability of MIPs, while the Raman-reporting molecules provide ultrasensitive signal amplification.
Solution Approach 2:
The patent introduces Raman-reporting molecules as intermediary agents that bind to the catecholamine target through host-guest complexation. These intermediaries convert the weak Raman signal of native catecholamines into strongly enhanced Raman signals, enabling picomolar detection without requiring direct detection of the target molecule itself.
2Measurement precision
If electrochemical sensors are used for DA detection, then high sensitivity can be achieved, but selectivity is reduced due to oxidation of electroactive interferents (ascorbic acid, uric acid) at similar potentials
Solution Approach 1:
The patent applies molecularly imprinted polymers (MIPs) with catecholamine-specific binding cavities that provide localized chemical recognition environments. These MIPs are functionalized on the SERS substrate to create specific binding sites that selectively recognize catecholamines through hydrogen bonding and pi-pi interactions, while rejecting structurally similar interferents like ascorbic acid and uric acid.
Solution Approach 2:
The patent uses Raman-reporting molecules as intermediaries that specifically complex with catecholamines through host-guest chemistry. This intermediary approach allows selective detection by designing the reporting molecule's binding pocket to accommodate only catecholamine structures, thereby excluding electroactive interferents that cannot form the same specific complexes.
3Measurement precision
If label-free SERS platforms are used to detect DA, then the detection method is simple and rapid, but specificity and sensitivity remain insufficient for diagnostic applications
Solution Approach 1:
The patent pre-functionalizes the SERS substrate with molecularly imprinted polymers (MIPs) and Raman-reporting molecules before sample analysis. This preliminary preparation creates a ready-to-use sensing platform with built-in specific recognition sites, eliminating the need for complex sample pre-treatment steps while achieving high specificity and sensitivity for catecholamine detection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the quantitative detection of catecholamines at extremely low concentrations, including dopamine, down to the picomolar range, providing improved sensitivity and specificity for diagnosing neurological diseases.
Implementation Method 1
a nanolaminate including a nanogap, a surface of the nanolaminate being modified with a compound that binds to a first functional group of the catecholamine; and a metal nanoparticle whose surface is modified with a compound that binds to a second functional group of the catecholamine
Implementation Method 2
Surface-enhanced Raman spectroscopy (SERS) has emerged as a promising biochemical detection technique, providing molecular fingerprint information with a rapid, non-destructive, and ultrasensitive detection capability down to the single-molecule level. The SERS is a technique of exploiting the surface plasmon enhancement of both the excitation and inelastic Raman scattering processes of molecules at plasmonic hotspots
Data Source
AI summary
The present disclosure relates to a surface-enhanced Raman spectroscopy complex probe capable of effectively detecting a catecholamine compound even at extremely low concentrations. The complex probe includes a nanolaminate including a nanogap and metal nanoparticles. In this case, the nanolaminate and the metal nanoparticles are modified to a compound that may be bound to each functional group included in catecholamine, and thus, catecholamine included in an analyte is doubly recognized by the complex probe. In addition, since a hotspot emitting a strong SERS signal is formed by a nanogap included in a nanolaminate, it is possible to effectively detect a catecholamine compound even at extremely low concentrations.